Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP...

  • Main
  • 2016 / 03
  • Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP...
Expert Opinion on Investigational Drugs 2016 / 03

Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP inhibitor, in combination therapy for high grade serous ovarian cancer

Ivy, S. Percy, Liu, Joyce F., Lee, Jung-Min, Matulonis, Ursula A., Kohn, Elise C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Expert Opinion on Investigational Drugs
DOI:
10.1517/13543784.2016.1156857
Date:
March, 2016
File:
PDF, 1.00 MB
english, 2016
Conversion to is in progress
Conversion to is failed